Global Surgical Drainage Devices Market was valued at US$ 1.3 Billion in 2021 and is expected to reach US$ 2.9 Billion by 2032, finds Future Market Insights (FMI) in a recent market survey. The growth of the market for Active Drains is projected to expand at a CAGR of around 7.7% during 2022 to 2032. The value of Active Drains Market increased at a CAGR of around 6.7% during 2017 to 2021.
Active drains are systems that collect fluid and deposit it in reservoirs. These reservoirs reduce hospital workers’ exposure to contaminated fluid. Active drains use an artificial pressure gradient to remove fluid from a wound or body cavity.
Request Sample Copy of Report@ https://www.futuremarketinsights.com/reports/sample/rep-gb-15869
According to the National Library of Medicine, patients with active drains experienced 6% delayed healing compared to 54% for those with passive drains.
Active drains play an important role in improving the outcome of cardiothoracic surgeries, especially in children. As a result, the use of active surgical drain devices among a wide range of end-users has increased along with an increase in the prevalence of chronic diseases like arthritis and osteoporosis. This appears to be primarily driven by significant progress in the medical device industry.
Top of Form
Bottom of Form
Competitive Landscape
Some of the key players in Surgical Drainage Devices include Acelity, Teleflex Incorporated, Cardinal Health, Medtronic, Cook Medical, Johnson and Johnson, B. Braun Melsungen AG, Smith & Nephew plc, Stryker, Becton Dickinson, and Centese.
Some of the recent developments of key surgical drains devices providers are as follows:
- In October 2021, Centese created a self-cleaning chest tube device that offers more accurate measurements for keeping tabs on patients recuperating from heart or lung surgery. The device developed by Centese is called the Thoraguard device. This device will help Centese accelerate its growth in the segment of surgical drainage devices.
- In April 2019, Smith & Nephew plc announced the acquisition of Osiris Therapeutics, Inc. This addition will further accelerate the growth of Smith & Nephew’s surgical drains business and advance the wound care franchise.
- In October 2019, 3M announced the acquisition of Acelity, Inc.
Ask an Analyst@ https://www.futuremarketinsights.com/ask-question/rep-gb-15869
More Insights Available
Future Market Insights, in its new offering, presents an unbiased analysis of the Surgical Drainage Devices Market, presenting historical market data (2017 to 2021) and forecast statistics for the period of 2022 to 2032.
Surgical Drainage Devices Market Segmentation
By Product Type:
- Active drains
- Passive drains
By Application:
- Thoracic and Cardiovascular Surgeries
- Neurosurgical Procedures
- Abdominal Surgery
- Orthopedics
- Other Applications
By End-Use:
- Hospitals
- Ambulatory Surgical Centers
- Clinics
Buy Complete Report@ https://www.futuremarketinsights.com/checkout/15869
About Future Market Insights (FMI)
Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.
Contact:
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Browse All Reports: https://www.futuremarketinsights.com/reports
LinkedIn| Twitter| Blogs